Drug Testing Locations - Concord, VA

Drug Testing in Concord, VA

Concord, Virginia Statistics

Between 2018 and 2021, Concord, VA, in Campbell County saw a 20% increase in opioid overdoses.

Concord, VA experienced a 15% rise in alcohol-related incidents from 2019 to 2022.

In 2020, Campbell County conducted over 300 drug-related arrests in Concord, VA.

Around 30% of high school students in Concord, VA reported trying prescription drugs in 2021.

Concord, VA saw opioid-related ER visits reduce by 10% from 2020 to 2021.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Concord, VA & Drug Testing Policies

Many employers in Concord, VA, have adopted stringent drug testing policies to ensure a safe work environment. These companies conduct pre-employment screenings and random tests to deter and detect drug usage among employees.

For guidance on implementing workplace drug testing policies, businesses in Concord can refer to resources provided by the U.S. Department of Labor. Compliance with federal and state guidelines ensures that both employee rights and safety are maintained.

Government Efforts with Drug Problems in Concord, VA

The government in Concord, VA, is taking significant measures to combat drug abuse. Campbell County has launched educational programs to raise awareness about the dangers of drug abuse. Local initiatives include community workshops and informational sessions.

At the state level, Virginia has implemented the Medicaid Addiction and Recovery Treatment Services (ARTS) benefit to expand treatment options for substance use disorders. More information can be found on the Virginia Department of Medical Assistance Services website.

Local Drug Busts & News in Concord, VA

Recently, Concord, VA, saw a significant drug bust that led to the confiscation of opioids worth over $100,000. The operation, conducted by Campbell County authorities, resulted in several arrests, highlighting the ongoing battle against drug trafficking in the region.

Community events such as drug take-back days are organized to allow residents to safely dispose of unused or expired medications. These events play a vital role in reducing the availability of prescription drugs on the streets.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Concord, VA. Trusted by employers nationwide for accurate results and exceptional service.

Virginia DOT/Non DOT Physicals

Virginia Vision Tests

Virginia Audiograms

Virginia Respirator Fit Tests

Virginia Lift Tests

Virginia Background Checks

Clinical Testing Services

TB Testing in VA

Diabetes Testing in VA

Infectious Disease Testing in VA

Sickle Cell Anemia Testing in VA

Women/Men's Health Testing in VA

Resources & Citations

Virginia Department of Health

Substance Abuse Support - Virginia.gov

Addiction and Recovery Treatment Services - Virginia

Disease Prevention and Substance Use Services

Recovery Centers in Concord, VA

Virginia Association of Community Services Boards

Substance Abuse and Mental Health Services Administration

National Institute on Drug Abuse

Drug Testing Near Concord, VA

King William, VA

West Point, VA

Scotland, VA

Seaford, VA

Jamestown, VA

Achilles, VA

Jamestown district, VA

Toano, VA

Gressitt, VA

Gloucester Point, VA

Williamsburg, VA

Gloucester Courthouse, VA

Gloucester, VA

Bellamy, VA

Frequently Asked Questions

Customer Reviews